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Introduction
The coordination of the cell cycle and differentiation is central
to metazoan development but is poorly understood. Cyclins
drive the cell cycle forward in conjunction with cyclin-
dependent kinases. Much of what we know about cyclin
activity comes from very detailed work using tissue culture
cells. D-type cyclins, bound to cdk4/6 act early in G1,
predominantly to phosphorylate Rb and allow G1 progression
via effects on the E2F transcription factors. Cyclin E/cdk2 is
then the main kinase complex needed for entry to S phase, after
which point cyclin A/cdk2 becomes active. Finally, cdc2 bound
to either an A- or B-type cyclin is needed for cells to enter
mitosis. Under certain circumstances, overexpression of cyclin
E or cyclin A alone is sufficient to drive cultured cells into or
through the cell cycle (Connell-Crowley et al., 1998; Ohtsubo
and Roberts, 1993; Ohtsubo et al., 1995; Resnitzky et al., 1994;
Resnitzky et al., 1995; Rosenberg et al., 1995).
Attempts have also been made to study the roles of different
cyclins during development, and most success has been gained
from taking a genetic approach in Drosophila. Overexpression
of cyclin E in flies induces both undifferentiated and
differentiating G1 cells to enter S phase in a variety of tissues
(Li et al., 1999; Neufeld et al., 1998; Richardson et al., 1995).
Ectopic overexpression of cyclin A also triggers entry into S
phase, although this is limited by additional embryonic
mechanisms that limit cyclin A activity, predominantly
affecting protein stability (Sprenger et al., 1997). Work on
tissue culture cells might imply that most, if not all, cyclins are
important for cell cycle progression in all cells. However, for
instance in Drosophila and Xenopus, expression patterns of
various cyclins differ between tissues in ways that cannot
always solely be explained by the proliferative index of the
tissue concerned (Jones et al., 2000; Richardson et al., 1993;
Vernon and Philpott, 2003a). In Xenopus embryos, our
experimental system of choice, cell division is fairly uniform
before gastrulation, but after this time proliferation adopts
tissue- and region-specific patterns (Saka and Smith, 2001;
Vernon and Philpott, 2003a). Methods of cell cycle regulation
might differ between these distinct regions.
A number of G1/S phase cyclins have been identified in
Xenopus. Although cyclin D has not been demonstrated to play
an important role in early Xenopus embryogenesis (T. Hunt,
personal communication) (see also Taieb et al., 1997; Taieb and
Jessus, 1996), 3 cyclin E (Chevalier et al., 1996; Rempel et al.,
1995) and 2 cyclin A homologues (Howe et al., 1995; Minshull
et al., 1990) have been cloned. Interestingly, maternal cyclin E
and cyclin A1 are degraded after the midblastula transition
(MBT) or at the onset of gastrulation, respectively (Howe et
al., 1995; Howe and Newport, 1996), and are replaced with
zygotic transcripts. Cyclin A1, the pre-MBT form of cyclin A,
complexes predominantly if not exclusively with cdc2,
functions in mitosis and is fully degraded after MBT. It is then
replaced by zygotic cyclin A2 (Howe et al., 1995). Cyclin A2
is found complexed with cdk2 and cdc2 soon after gastrulation
but predominantly complexes with cdk2 from neurula stages
onwards (Howe et al., 1995; Strausfeld et al., 1996). Thus,
Xenopus cyclin A2 behaves more like a homologue of
mammalian cyclin A than Xenopus cyclin A1 does, functioning
Cell division and differentiation are largely incompatible
but the molecular links between the two processes are
poorly understood. Here, we overexpress G1/S phase
cyclins and cyclin-dependent kinases in Xenopus embryos
to determine their effect on early development and
differentiation. Overexpression of cyclin E prior to the
midblastula transition (MBT), with or without cdk2,
results in a loss of nuclear DNA and subsequent apoptosis
at early gastrula stages. By contrast, overexpressed cyclin
A2 protein does not affect early development and, when
stabilised by binding to cdk2, persists to tailbud stages.
Overexpression of cyclin A2/cdk2 in post-MBT embryos
results in increased proliferation specifically in the
epidermis with concomitant disruption of skin architecture
and delay in differentiation. Moreover, ectopic cyclin
A2/cdk2 also inhibits differentiation of primary neurons
but does not affect muscle. Thus, overexpression of a single
G1/S phase cyclin/cdk pair disrupts the balance between
division and differentiation in the early vertebrate embryo
in a tissue-specific manner.
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in S-phase entry (Strausfeld et al., 1996). Both cyclin E1 and
cyclin A2 are detectable by in-situ hybridisation at least
through to tailbud stages, although levels and sites of
expression appear to differ somewhat at different
developmental stages (Vernon and Philpott, 2003a).
Cell division and differentiation are generally thought to be
mutually exclusive (e.g. Edlund and Jessell, 1999; Skapek
et al., 1995; Zhang et al., 1999). While the effects of
overexpression of cyclins and cdks have been studied in
Drosophila, and some targeted expression has been attempted
in mammals (Li et al., 1999; Miliani de Marval et al., 2001;
Neufeld et al., 1998; Robles et al., 1996; Rodriguez-Puebla et
al., 2000; Yamamoto et al., 2002), little work has been
performed to investigate the short- and long-term effects of
cyclin/cdk upregulation in multiple tissues in the vertebrate
embryo in vivo. The aim of this study was to determine
whether overexpression of a single cyclin/cdk pair alone was
sufficient to promote proliferation in the early embryo, and to
investigate whether this was incompatible with differentiation.
Here, we demonstrate that, while overexpression of cyclin E
results in apoptosis post-MBT, cyclin A2/cdk2 overexpression
promotes proliferation in the early tailbud embryo. Moreover,
cyclin A2/cdk2 RNA injection delays differentiation of
epidermis and neurons but has no effect on differentiation of
muscle. Thus, cyclin E and cyclin A2 levels can regulate cell
cycle and differentiation in a stage- and tissue-specific manner.
Materials and methods
Embryos and injections
Xenopus laevis embryos obtained by hormone-induced laying were
fertilised in vitro, de-jellied in 2% cysteine, pH 7.8-8.0, washed
and incubated in 0.1 · MBS. Embryos were staged according to
Nieuwkoop and Faber (Nieuwkoop and Faber, 1984), fixed and
stained for beta-galactosidase (Bgal) as described (Sive et al., 2000).
Xenopus cyclin E1, cyclin A2, and cdk2 (the latter two with
or without myc-tag or HA-tag) were subcloned into pCS2+ and
transcribed using the Ambion Message Machine kit. Typically, 1 ng
of each RNA was injected (2 ng in Fig. 2G,H; 1.5 ng in Fig. 6). Where
appropriate, 100 pg of Bgal was injected as a lineage tracer.
Kinase assays
Embryos were injected with the RNAs described and homogenised at
stage 8, 9 or 23 (as labelled). H1 kinase assays were performed on
cdk2 complexes immunoprecipitated from embryo extracts, as
described in Philpott et al. (1997), approximately one embryo per
lane.
In situ hybridisation, BrdU detection, antibody staining
and histology
Whole-mount in-situ hybridisations were performed as described
(Shimamura et al., 1994) with digoxigenin-labelled antisense RNA
probes generated from epidermal keratin (EcoRI/SP6), neural-beta-
tubulin (BamHI/T3) and muscle actin (HindIII/T7) clones. BrdU
incorporation and detection was performed essentially as described in
the Roche (Roche, Mannheim, Germany) instructions for the BrdU
Labelling and detection kit 1 (1296 736). Embryos were injected with
1 nmol of BrdU 1 hour before MEMFA fixation. Anti-BrdU (1:100)
was applied to 12 m m paraffin wax embedded sections overnight at
4° C, washed and detected with an anti-mouse Ig-rhodamine (1:200)
for 1 hour at room temperature.
Whole-mount antibody staining was performed as described (Sive
et al., 2000) using an anti-phosphohistone H3 antibody (TCS
Biologicals, Buckingham, UK) at 1:1000 and detected with an
alkaline phosphatase-conjugated secondary antibody using
NBT/BCIP as substrates. Staining for skin differentiation (Fig. 6) and
HA-tagged cyclin A2 (Fig. 4) was performed on embryos, fixed in 4%
paraformaldehyde and sectioned by cryostat, using monoclonal
antibody culture supernatant (Jones and Woodland, 1986) diluted 1:1
with PBS, or anti-HA at 1:250. For whole-mount staining of nuclei,
embryos were fixed in MEMFA for 1-2 hours, bleached and stained
with Hoechst at 10 m g/ml in PBS. Embryos were de-stained in PBS
for at least 12 hours, then animal caps were cut, mounted under
coverslips and viewed directly.
Western blotting was performed by standard methods and blots
were probed with a monoclonal antibody to Xenopus cyclin A2,
generously provided by Dr Tim Hunt.
Results
The aim of this study was to investigate the effect of global
overexpression of G1/S phase cyclin-dependent kinase activity
on cell proliferation and differentiation in the embryo. Initially,
we overexpressed both E and A-type cyclins to determine
whether these would promote cell division and whether
differences existed between the two molecules.
To establish whether overexpression of G1/S phase cyclins
was able to increase cdk2 kinase activity in embryonic
blastomeres, RNAs encoding Xenopus cyclin A2 or cyclin E
were injected into fertilised eggs with or without RNA
encoding cdk2. At stage 8, after embryo homogenisation,
cdk was immunoprecipitated and tested for its ability to
phosphorylate histone H1 (Fig. 1). Injection of RNAs encoding
the cyclin subunits alone did not result in a significant increase
in cdk2 kinase activity, indicating that either the amount of
cdk2 in the extract was limiting or that the newly-synthesised
cyclin was unable to complex with or activate the endogenous
cdk2 (Fig. 1, lanes 1, 2 and 6). In fact, we observed that
overexpression of cdk2 alone led to a modest increase in cdk2
kinase activity (Fig.1, lane 3), indicating that the amount of
cdk2 subunit in the early embryo was limiting and that there
might have been uncomplexed cyclins present. Overexpression
of cyclin E in particular was able to upregulate cdk2 kinase
activity when exogenous cdk2 was introduced by RNA
injection (Fig.1, lane 4), showing that active complexes can be
formed from injected messages. In this system, neither cyclin
A2 nor cyclin E overexpression resulted in appreciable
activation of endogenous cdc2, as measured by
immunoprecipitation assays (data not shown).
To investigate the effects of overexpression of cyclins and
cdks on development, RNAs encoding Xenopus cyclin A2 and
E1 were injected into one of two blastomeres at the two-cell
stage (Fig. 2). At early stages pre-MBT, cyclin A2 at this level
had very little effect on blastomere cleavage, either with or
without co-injected cdk2 RNA (Fig. 2b,e), nor did injection of
cdk2 alone or Bgal as a control (Fig. 2c,f). However, a subtle
but reproducible slowing in the rate of blastomere cleavage was
observed in embryos injected with cyclin E RNA by around
stage 5, such that blastomeres around the site of injection were
typically delayed by one to two cleavages compared with
blastomeres in the uninjected side (Fig. 2a,d). When viewed
again at midgastrula stage, embryos expressing cyclin A2, with
or without cdk2, continued to develop essentially normally
(Fig. 2B,E), although some modest slowing of cleavage was
occasionally observed. By contrast, embryos injected with
cyclin E or cyclin E/cdk2 showed extensive cell death on the
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injected side; cells dissociated from their neighbours and
adopted a marbled appearance (Fig. 2A,D). The timing and
morphology of these regions was entirely consistent with
changes resulting from apoptosis, as documented previously in
Xenopus embryos (Hensey and Gautier, 1997; Sible et al.,
1997; Stack and Newport, 1997). Moreover, co-injection of
the inhibitor of apoptosis Bcl-XL (Bellmeyer et al., 2003)
prevented cell death, confirming that these cells were apoptotic
(Fig. 2G,H).
Thus elevated levels of cyclin E, but not cyclin A2, induce
apoptosis in the early embryo. This effect must be independent
of the ability of cyclin E to globally raise cdk2 kinase
activity because cyclin E injection alone, which does not
significantly activate endogenous cdk2 kinase as measured in
immunoprecipitation assays (Fig. 1, lane 1), is as efficient as
cyclin E plus cdk2 at inducing apoptosis. One possible trigger
for apoptosis is the disruption of the normal nuclear replication
and division cycle. To investigate this, we cut animal caps from
cyclin-injected embryos at stage 8.5 and stained them for DNA
content (Fig. 3). Large areas of the animal pole where cyclin E
message had been injected were devoid of any detectable nuclei
(Fig. 3A, arrow). This lack of nuclei is consistent with elevated
levels of cyclin E specifically blocking DNA replication, as has
been demonstrated in egg extracts (Hua et al., 1997). This block
would result in nuclear loss on subsequent cell division.
However, even in the absence of DNA cell cleavage would
continue, as embryos are able to sense this loss of nuclei only
after the MBT when checkpoints kick in (Dasso and Newport,
1990) and when apoptotic pathways are activated in the early
gastrula (Hensey and Gautier, 1997; Sible et al., 1997; Stack
and Newport, 1997). Interestingly, overexpression of cyclin E
resulted in loss of nuclei with or without co-injection of cdk2
(Fig. 3A,D). Therefore, the ability of cyclin E to induce nuclear
loss in Xenopus embryos is independent of an effect on overall
cdk2 kinase activity. Injections of RNA encoding cyclin A2
with or without cdk2, cdk2 alone or control Bgal had no effect
on nuclear density within the dissected animal caps, as might
be expected since these embryos develop essentially normally
(Fig. 2B,E,C,F and see below).
The finding that cyclin E overexpression resulted in nuclear
loss and apoptosis at MBT precluded us from further study to
investigate the effect of its overexpression on later embryonic
development. Instead we concentrated on studying the effect
of cyclin A2 overexpression, which has no apparent adverse
effects on the pre-MBT embryo.
We initiated experiments to determine the long-term effects
of cyclin A2 overexpression on later stages of Xenopus
development. As endogenous A-type cyclins are thought to be
unstable (Funakoshi et al., 1999; Howe et al., 1995), we
investigated whether cyclin A2 protein would be maintained at
high levels as late as tailbud stages (stage 23) after injection of
cyclin RNA into 2-cell embryos. Embryos injected with RNA
encoding cyclin A2, cdk2, cyclin A2 and cdk2 together or Bgal
as a control were allowed to develop until stage 23. Cdk2 was
then immunoprecipitated and tested for kinase activity against
histone H1 (Fig. 4A). Again, cyclin A2 alone was not able to
significantly activate endogenous cdk2 even post-MBT (Fig.
4A, lane 3) but cyclin A2 co-injected with cdk2 RNA led to a
substantial enhancement of cdk2 kinase activity (Fig. 4A, lane
4), even as late as stage 23 (tailbud stage).
Levels of cyclin A2 protein were measured by Western
blotting (Fig. 4B). As development progressed, cyclin A2
protein accumulated in injected embryos (Fig. 4B, compare
lanes 2 and 5). Furthermore, simultaneous overexpression of
Fig. 1. Activation of H1 kinase activity by overexpression of cyclins
and cdk2. RNA encoding cyclin E alone or with cdk2, cyclin A2
alone or with cdk2, or cdk2 alone were injected into fertilised eggs
and allowed to develop until stage 8. Cdk2 was immunoprecipitated
from injected embryos (lanes as labelled) and tested for its ability to
phosphorylate histone H1.
Fig. 2. Cyclin E but not cyclin A2 overexpression leads to apoptosis
in the gastrula embryo. RNAs encoding cyclin E alone (a,A) or
cyclin E with cdk2 (d,D,G), cyclin A2 alone (b,B) or cyclin A2 with
cdk2 (e,E), cdk2 alone (f,F), Bgal as a control (c,C) or cyclin E with
cdk2 and BclXL (H) were injected into one cell of a 2-cell embryo
and allowed to develop to stage 9 (a-f) or stage 11 (A-H). Areas of
slowed cell division are indicated by black arrows (a,d,H). Areas of
apoptosis are indicated by white arrows (A,D,G).
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cdk2 substantially stabilised overexpressed cyclin A2 protein
(Fig. 4B, lane 6). This effect might be analogous to
stabilisation of cyclin E seen on binding to cdk2 in mammalian
cells (Clurman et al., 1996). However, this stabilisation effect
is not seen at stage 9, possibly because little injected cyclin A2
has accumulated at this time (Fig. 4B, compare lanes 2, 3 and
7) or due to regulated and abrupt degradation of A-type cyclins
at the onset of gastrulation (Howe et al., 1995). To maintain
cyclin A2-dependent kinase activity at high levels in older
embryos that we studied in the following experiments, we co-
injected cyclin A2 with cdk2 (cyclin A2/cdk2 RNA).
To investigate the stability of cyclin A2 protein in different
tissues, we injected embryos with HA-cyclin A2/cdk2 RNA
and allowed them to develop to stage 23. Embryos were
sectioned and immunostained for expression of HA-tagged
cyclinA2. We saw no overall difference in protein stability
between epidermis, notochord, myotome or neural tube in the
injected region (Fig. 4C,D). However, there was cell-to-cell
variability, as expected from a protein that is degraded in a cell
cycle-dependent manner. Cdk2 protein was also equally stable
in all these tissue types (data not shown).
Next, to establish whether overexpression of cyclin A2
kinase is sufficient to force cells through the cell cycle, we
injected cyclin A2/cdk2 RNA, along with Bgal as a lineage
tracer, into one cell of a two-cell embryo. Embryos were
allowed to develop to stages 16 and 19 when we investigated
proliferation on the injected versus the uninjected side. We
used the mitotic marker phosphorylated histone H3 to visualise
proliferation and measured the number of cells in mitosis (Saka
and Smith, 2001). To quantitate cellular proliferation, regions
of equal size were drawn on the flank of the embryo on the
injected versus the uninjected side and the number of
phosphorylated histone H3-expressing cells were counted. On
average, 46% more cells at stage 16 (n=20) and 63% more cells
at stage 19 (n=12) (Fig. 5A,C) were undergoing mitosis on the
skin of the injected side of the embryo compared with the
uninjected side. By contrast, Bgal-injected control embryos
showed no increase in number of phosphorylated histone H3-
expressing cells on the injected side (data not shown).
Therefore, overexpression of cyclin A2/cdk2 is able to increase
cellular proliferation after MBT.
To determine its effect on S-phase entry in tissues
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Fig. 3. Cyclin E overexpression results in nuclear loss. RNAs
encoding cyclin E1 alone (A) or cyclin E1 with cdk2 (D), cyclin A2
alone (B) or cyclin A2 with cdk2 (E), cdk2 alone (C) or b -gal as a
control (F) were injected into one cell of a 2-cell embryo and allowed
to develop to stage 8.5. Embryos were fixed, depigmented and the
DNA stained with Hoechst. Animal caps were dissected and viewed
by fluorescence microscopy. White arrows indicate regions in which
nuclei are absent.
Fig. 4. Cyclin A2/cdk2 overexpression is sustained throughout early
development. (A) Embryos were injected with RNA encoding cdk2,
cyclin A2, cyclin A2 with cdk2, or Bgal as a control. Embryos were
allowed to develop to stage 23, then immunoprecipitated cdk2 from
injected embryos was tested for its ability to phosphorylate histone
H1. (B) Embryos were injected with RNA encoding cyclin A2, cdk2,
cyclin A2 with cdk2 or GFP as control and allowed to develop to
stage 9 (lanes 1-3, 7) or stage 23 (lanes 4-6, 8). Extracts from
embryos, injected as labelled, were western blotted to detect cyclin
A2 protein levels. (C,D) Cyclin A2/cdk2-injected embryos were
grown until tailbud stages (injected side to the right). Tagged cyclin
A2 is stable in all tissues on the injected side (D), including neural
tube (nt), notochord (no), muscle (m) and epidermis (ep); see
Hoechst staining of the same section (C).
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throughout the embryo, cyclin A2/cdk2 RNA was injected into
one cell at the 2-cell stage along with Bgal as a lineage tracer.
Because the first cleavage in Xenopus embryos usually
determines bilateral symmetry, RNAs are incorporated
unilaterally into one side of the embryo, so injected and
uninjected sides can be directly compared. At stage 23,
bromodeoxyuridine (BrdU) was injected into the archenteron,
and after 1 hour the embryos were fixed, sectioned and stained
for BrdU incorporation. BrdU incorporation was enhanced in
epidermis on the injected side (Fig. 5, compare C and B),
where 69% of cells showed incorporation compared with
52% on the uninjected side (P<0.05). Moreover, while the
uninjected sides of the embryos showed normal skin
morphology, in which the epidermis is two cell layers thick and
cells are flattened along the surface of the embryo (Fig. 5B),
regions where cyclin A2 and cdk2 were most strongly
overexpressed, as judged by a co-expressed Bgal marker,
showed pronounced thickening. In these regions, the epidermis
thickened up to five or six cell layers and cells often lost their
flattened appearance (Fig. 5C). Whole-mount TUNEL staining
did not reveal a significant increase in the number of apoptotic
cells in the skin after cyclin A2/cdk2 overexpression at this
level (data not shown). Thus, cyclin A2/cdk2 overexpression
clearly promotes proliferation in the embryonic skin, a tissue
in which cyclin A2 is usually expressed at a low level (Vernon
and Philpott, 2003a).
To investigate whether cyclin A2/cdk2 overexpression
would similarly promote proliferation in other early embryonic
tissues, numbers of BrdU-labelled cells were counted in each
half of the neural tube and myotome. There was no significant
difference in the number of cells incorporating BrdU on the
injected versus the uninjected side in these tissues (Fig.
5E,F,G): on average 15% BrdU-positive cells on the injected
side versus 16% on the uninjected side for the muscle section
and on average 54% BrdU-positive cells on both injected and
uninjected sides for the neural tube. Nor was the myotomal
tissue area visibly changed. Similarly, cyclin A2/cdk2
overexpression did not lead to proliferation in the notochord
(Fig. 5E), which is postmitotic by this stage (Saka and Smith,
2001). These data indicate that in nerve and muscle at this stage
any increased proliferative signal given by cyclin A2/cdk2
overexpression is overridden by intrinsic or extrinsic factors
that control the rate of cell division. However, this is clearly
not the case in the skin, in which cyclin A2/cdk2
overexpression alone can promote cell cycling.
While cyclin A2/cdk2 overexpression promotes ectopic cell
division, we wanted to know whether these cells divide more
rapidly, i.e. at a smaller size. To measure approximate cell size,
we measured the average internuclear distance along the
surface of either normal or thickened skin to produce a
measurement of average cell diameter. In a typical experiment,
internuclear distance was 26.3 m m– 1.27 on the injected side
versus 24.7 m m– 1.22 on the uninjected side (n=11),
demonstrating that there is not a significant difference in cell
size in cyclin A2/cdk2-overexpressing regions and the control
non-expressing regions. These data indicate that cyclin
A2/cdk2 upregulation is not sufficient to allow cells to
proliferate at a smaller than normal size.
Cells in the developing embryo are subject to many signals,
extrinsic and intrinsic, which instruct cells to divide or to
Fig. 5. Cyclin A2/cdk2 overexpression
promotes cell proliferation in the
embryonic epidermis. Embryos were
injected into one cell at the 2-cell stage
with cyclin A2 and cdk2 RNA along
with Bgal (light blue). (A) Whole-
mount immunostaining with
antiphosphohistone H3 antibodies
shows an increase in cell proliferation
on the injected side (left).
(B-G) Cyclin A2/cdk2-injected
embryos were grown until tailbud
stages and then allowed to incorporate
BrdU for 1 hour before fixing (B,C,E;
BrdU uptake) red; nuclei stained in
blue with Hoechst dye; bottom left of
each panel: b -gal auto-fluorescence.
Epidermis overexpressing cyclin
A2/cdk2 (C) is disorganised and shows
increased BrdU incorporation
compared with epidermis on the
uninjected side (B). By contrast, cell
proliferation does not differ in the
neural tube and muscle between the
injected side (left) and the uninjected
side (right) (E). (D,F,G) Number of
BrdU-positive cells expressed as a
percentage of total number of nuclei
(Hoechst-positive) were counted in
regions of equal side on the injected
and uninjected sides of the embryos. BrdU incorporation is increased in the epidermis on the injected side compared with the uninjected side of
embryos (D). No significant difference in BrdU incorporation is seen for muscle (F) and neural tube (G).
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differentiate. While it has become increasingly apparent that
cells must exit the cell cycle before terminal differentiation
can occur, the ways in which cell cycle regulators and
differentiation factors are coordinated is obscure. We wished
to determine whether overexpression of cyclin A2/cdk2 alone
was enough to overcome endogenous signals within the
embryo promoting differentiation of the skin. First, we allowed
injected embryos to grow up to tailbud stages and viewed them
externally. We observed that overexpression of cyclin A2/cdk2,
but not cyclin A2 alone or cdk2 alone, resulted in regions of
hyperpigmentation in the injected region of the embryo,
indicating that normal skin formation or architecture had been
disrupted. This hyperpigmentation was often accompanied by
raised regions of epidermis (‘lumps’, Fig. 6G, arrow). The
penetrance of these phenotypes varied somewhat from batch to
batch of embryos, but a typical experiment is shown in Table
1. However, we noted that even where hyperpigmentation and
lumps were visible, skin integrity was always maintained,
indicating that epidermal differentiation was occurring.
To investigate this further, we studied expression of 2F7.C7
(epi), a marker of differentiation of the surface layer of the skin.
This marker first appears at the onset of neurulation in cells
differentiating into the outer layer of the epidermis and
becomes stronger as development progresses (Jones and
Woodland, 1986). Embryos were injected in one cell at the
two-cell stage with RNAs encoding cyclin A2 and cdk2 along
with GFP as a tracer. Bgal RNA was injected along with GFP
as a control in parallel embryos. Embryos were allowed to
develop to stage 23, then sectioned and stained for the
expression of epi (Fig. 6). Epi was strongly expressed in the
outermost cell layer of the control-injected embryos (Fig. 6D).
Epi was also clearly seen in skin expressing cyclin A2/cdk2 at
the same level as that seen in the control at this stage (Fig. 6A).
However, while staining in control embryos was confined to
the surface of the outermost layer of the epidermis, cyclin
A2/cdk2-expressing embryos displayed staining deep in deep
cell layers (Fig. 6A, arrow), indicating disrupted epidermal
architecture. Hyperpigmentation might also be caused by this
disrupted architecture, as pigment was also seen in deep skin
layers in injected regions (data not shown). Thus, although
cyclin A2/cdk2 overexpression causes inappropriate
proliferation in the skin, overexpressing cells are still
competent to respond to signals that promote terminal
differentiation. Indeed, these extra cells differentiate even in
their inappropriate position under the surface skin layer.
Thus, while overexpression of cyclinA2/cdk2 does not
prevent epidermal differentiation, we wished to determine
whether it was sufficient to delay differentiation in embryonic
tissues. Hence, we injected cyclinA2/cdk2 RNA and allowed
embryos to develop to neural plate and tailbud stages. Embryos
at increasing developmental stages were stained by in-situ
hybridisation for expression of: the skin marker epidermal
keratin; the somatic muscle marker muscle actin; and neural
beta tubulin, a marker of primary neurons, which are the first
neurons to differentiate within the neural plate (Fig. 7). After
cyclin A2/cdk2 overexpression, epidermal keratin expression
was significantly delayed on the injected side of the embryo
until stage 18 (Fig. 7A-C) while primary neurons failed to
differentiate until tailbud stages (Fig. 7D-F). By contrast,
expression of muscle actin (or the terminal muscle marker
heavy chain myosin, data not shown) was not delayed by
overexpression of cyclin A2/cdk2 (Fig. 7G-I). Thus, simple
upregulation of a single cyclin/cdk pair is sufficient to
overcome endogenous signals to differentiate, but only for a
limited time and only in specific tissues.
Discussion
Much of what we know about the cell cycle has been derived
from studies on single-celled organisms such as yeast, on tissue
culture cells and on simplified cell cycles in amphibian eggs.
None of these systems displays the complexity of regulation
required in a multicellular organism to coordinate the complex
patterns of cell division and differentiation that allow proper
patterning of the early embryo. Where whole-organism studies
have been attempted, perturbation of cyclin/cdk levels in
Drosophila has led to significant disruption of cell division
patterns in the tissues thus far studied (Duronio and O’Farrell,
1995; Jacobs et al., 2001; Knoblich et al., 1994; Li et al., 1999;
Richardson et al., 1995; Sprenger et al., 1997). Targeted
overexpression of D-type cyclins and cdk4 via transgenesis in
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Table 1. Effects of cyclin A2 and cdk2 injection
Injected? Normal Hyperpigmented Hyperpigmented + lumps
Cyclin A2 45 2 0
cdk2 48 0 0
Cyclin A2 + cdk2 12 15 20
Uninjected 48 0 0
Table shows the number of embryos exhibiting regions of
hyperpigmentation, with or without raised lumps following injection of cyclin
A2 and cdk2, alone or in combination, as indicated.
Fig. 6. Cyclin A2/cdk2
overexpression results in
disruption of skin architecture.
Embryos were injected with
RNAs encoding cyclin A2 with
cdk2 (A-C) or b -gal as a control
(D-F), along with GFP as a
lineage tracer. Embryos were
fixed at stage 23, sectioned, then
stained for expression of the skin
marker, epi (A,D), confined to the epidermis in these sections.
Region of epi expression deep within the thickened skin is indicated
by a white arrow. GFP fluorescence (B,E). DNA is stained with
Hoechst in blue (C,F). Alternatively, uninjected embryos or embryos
injected with RNAs encoding cyclin A2/cdk2, as indicated, were
photographed in whole-mount (G). A raised hyperpigmented lump,
which often formed after cyclin A2/cdk2 injection, is indicated by
the black arrow.
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mice has also been performed, largely in the epidermis and
thymus (Miliani de Marval et al., 2001; Robles et al., 1996;
Rodriguez-Puebla et al., 2000; Yamamoto et al., 2002).
However, generalised overexpression of a cyclin/cdk pair in
multiple tissues in a vertebrate embryo has not been attempted.
To investigate the effects of a widespread increase in
cyclin/cdk2 kinase activity in Xenopus embryos, we chose to
overexpress E- and A-type cyclins.
In mammalian cell cycles, data that come largely from
experiments in cultured cell systems suggest that accumulation
of the cyclin, rather than the amount of cdk subunit, is rate-
limiting for generation of cdk2-dependent H1 kinase activity
and subsequent cell cycle progression (Connell-Crowley et al.,
1998; Ohtsubo and Roberts, 1993; Ohtsubo et al., 1995;
Resnitzky et al., 1994; Resnitzky et al., 1995; Rosenberg et al.,
1995). Strikingly in the pre-MBT embryo, this assumption
seems not to hold true: overexpression of either cyclin E1 or
cyclin A2 alone did not produce a significant increase in cdk2
kinase activity in embryo extracts (Fig. 1) (Strausfeld et al.,
1996). While free cdk2 that is unable to complex with
overexpressed cyclin E1 or A2 may exist in the embryo,
overexpression of cdk2 alone by RNA injection also enhanced
cdk2-dependent H1 kinase activity. This finding indicates that
there may in fact be a pool of excess cyclins in pre-MBT
embryos. Cyclin/cdk overexpression is unlikely to be titrating
out cdk inhibitors (cdkis) at this stage, as the only described
cdki in Xenopus, Xic1, is not expressed at significant levels
prior to MBT (Shou and Dunphy, 1996; Su et al., 1995).
Microinjection of cyclin E RNA into Xenopus embryos
resulted only in a mild slowing of cell cleavage pre-MBT.
However, on closer inspection of dissected animal pole tissue,
we determined that nuclei were largely absent from injected
areas, even though cleavage had occurred. This observation is
consistent with elevated levels of cyclin E blocking DNA
replication, as has been demonstrated in egg extracts (Hua et
al., 1997), which would result in nuclear loss on subsequent
cell division. The fact that cleavage proceeds in the absence of
nuclear DNA when cyclin E is overexpressed (Fig. 2)
demonstrates the absence of active checkpoints in the embryo
pre-MBT that monitor DNA replication and/or genome
stability and chromosome segregation (Dasso and Newport,
1990). However, some slowing of cleavage does occur in the
most highly overexpressing regions at this early stage (Fig.
2a,d, arrows), indicating either that nuclear events can be
sensed to some extent or that cyclin E overexpression has a
direct effect on cleavage events, possibly via an effect on
centrosome duplication (Hinchcliffe et al., 1999) or on cdc2
activity. Apoptosis in these cyclin E-injected embryos, which
apparently occurs in response to the absence of nuclear DNA,
occurs at gastrula stages, when the apoptosis machinery
becomes activated (Hensey and Gautier, 1997; Sible et al.,
1997; Stack and Newport, 1997). Interestingly, overexpression
of cyclin E in mammalian cells does not block DNA
replication, nor does it result in obvious apoptosis (Ohtsubo
and Roberts, 1993; Ohtsubo et al., 1995; Resnitzky et al.,
1994), but instead it promotes genetic instability (Spruck et al.,
1999). Cyclin E is often highly expressed in tumours
(Donnellan and Chetty, 1999), and the genetic instability
caused could lead to loss of genes involved in apoptotic
pathways in the outgrowing cells.
Importantly, we note that loss of nuclear DNA occurs after
injection of cyclin E message alone, with or without additional
cdk2. As overexpression of cyclin E alone does not lead to an
overall increase in the level of immunoprecipitable cdk2 kinase
activity (Fig. 1), nor will it activate cdc2 (data not shown), it
is possible that increased kinase activity is not required to
produce cyclin E-induced loss of nuclei. Alternatively, cyclin
E overexpression might raise kinase activity only locally,
which is not detected by overall cdk2 immunoprecipitation
from lysed embryos, and this local activation might be
sufficient to induce nuclear loss. Overexpression of cyclin A2
with or without cdk2 has no appreciable effect on either cell
or nuclear division prior to MBT. This observation
demonstrates that overexpression of cyclin E has specific
effects that are not recapitulated by overexpression of cyclin
A2, indicating distinct targets for these two molecules. This
difference is surprising, given that endogenous cyclin A2 can
compensate for the requirement of cyclin E for DNA
replication in egg extracts (Jackson et al., 1995).
While the effect of cyclin E overexpression on nuclear
maintenance in vivo is interesting and deserves further study,
the focus of this work was to determine the effects of
cyclin/cdk overexpression on development after the MBT. As
overexpression of cyclin E induces apoptosis at gastrulation,
we chose to concentrate on the effects of cyclin A2/cdk2
overexpression on later developmental processes.
Studies of phosphohistone H3 distribution in Xenopus
demonstrated that cell proliferation is widespread in many
areas of the neurula and tailbud stage embryo (Saka and Smith,
2001). We find that cyclin E1 and cyclin A2 messages have
Fig. 7. Cyclin A2/cdk2 delays differentiation of epidermis and
neurons. Whole-mount in-situ hybridisation analysis shows a delay
in skin differentiation (A-C: epidermal keratin, stage 14, 16 and 18,
respectively); and neural differentiation (D-F: neural b tubulin, stage
14, 19 and 25, respectively) in embryos injected with cyclin A2 and
cdk2 RNA (injected side to the left, indicated by asterisks).
Differentiation of the muscle is not affected (G-I: muscle actin, stage
13, 16 and 21, respectively). 
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overlapping distributions and are most highly expressed in the
anterior neural tube (Vernon and Philpott, 2003a). While this
distribution might be expected, since the neural tube is one of
the most actively proliferating tissues at this time (Saka and
Smith, 2001), it is surprising that expression is strikingly lower
in other tissues that are still dividing at these stages, such as
the embryonic epidermis (Saka and Smith, 2001; Vernon and
Philpott, 2003a). Overexpression of cyclin A2/cdk2 alone is
enough to promote enhanced proliferation in the embryo
(Fig. 5). However, a dramatic increase in the proportion of
proliferating cells occurs only in the epidermis. Strikingly,
cyclin A2/cdk2 overexpression apparently cannot promote
proliferation in the notochord or myotome, where cells
normally exit the cell cycle at early to mid-neural plate stages
(Fig. 5E,F) (Saka and Smith, 2001; Vernon and Philpott,
2003b), even though the proteins are stable in these tissues
(Fig. 4C,D). Moreover, proliferation is not enhanced in the
neural tube (Fig. 5G), where cyclin messages are normally
abundant (Vernon and Philpott, 2003a). This indicates that in
tailbud-stage embryos, of the tissues studied, cyclin A2/cdk2
overexpression is limiting only for proliferation in the skin,
where G1/S phase cyclin message levels are usually low but
where many cells are still proliferating (Vernon and Philpott,
2003a). This might reflect the fact that there are high levels of
the cdk inhibitor Xic1 in the myotome, nervous system and
notochord but only low levels in the epidermis (Hardcastle and
Papalopulu, 2000; Ohnuma et al., 1999; Vernon et al., 2003;
Vernon and Philpott, 2003b), and indicate that different tissues
emphasise different methods of cell cycle regulation during
embryogenesis.
Studies in Drosophila have shown that overexpression of
cyclin E can result in cells dividing at a smaller size than usual,
but the final area occupied by overexpressing cells is normal
as extra cells are lost by apoptosis (Li et al., 1999).
Interestingly, in some circumstances, while cyclin E
overexpression accelerates passage through G1 phase, cell
cycle length is not changed as there is a corresponding
lengthening of S phase (Neufeld et al., 1998). By contrast,
overexpression of E2F, a transcription factor required to
upregulate a variety of S-phase progression factors as well as
the M-phase String protein, accelerates the cell cycle.
However, this accelerated proliferation correlates with
decreased cell size, thus tissue volume is not affected (Neufeld
et al., 1998). To determine whether cyclin A2/cdk2
overexpression caused cells to divide at a smaller than usual
size, we measured the internuclear distance between cells
overexpressing cyclin A2/cdk2 compared with uninjected cells
in skin sections and found no significant difference. This is
indicative of cell division occurring at normal cell size. Indeed,
in cyclin A2/cdk2 overexpressing embryos, tissue expressing
epidermal markers is more than the usual two cell layers thick
(Fig. 6), again indicating that cells do not divide at a smaller
size, but instead continue proliferating when they would
normally have exited the cell cycle and so must occupy a
greater than usual volume (Zuber et al., 1999). Therefore,
cyclin A2/cdk2 overexpression appears to be insufficient to
accelerate the overall cell cycle rate at the expense of cell
growth in a vertebrate embryo, but instead it prolongs the
period of proliferation.
In most systems, proliferation and differentiation are
mutually exclusive. We wished to determine whether
overexpression of cyclin A2/cdk2 delayed or prevented
differentiation in the early embryo. Cyclin A2/cdk2
overexpression was able to significantly delay the appearance
of epidermal keratin (Fig. 7A-C). However, differentiation did
eventually occur (Fig. 6A; Fig. 7C), demonstrating that
promotion of cell cycling in this way is sufficient to delay, but
not to overcome, signals promoting epidermal differentiation.
Mice have been generated in which D-type cyclins or cdk4 are
specifically upregulated in epithelia, especially in the skin, and
this results in hyperproliferation of the epidermis (Miliani de
Marval et al., 2001; Robles et al., 1996; Rodriguez-Puebla et
al., 2000; Yamamoto et al., 2002). Interestingly, under these
circumstances differentiation appears to be largely normal. We
note that D-type cyclins, which act in G1 phase of the cell cycle
and earlier than cyclin E or cyclin A, are not detected in the
epidermis of Xenopus embryos (Vernon and Philpott, 2003a).
The mammalian skin condition psoriasis results from
hyperproliferation and thickening of the epidermis coupled to
perturbed differentiation. Although epidermis structure differs
significantly between species, we see a strikingly similar
phenotype on overexpressing cyclin A/cdk2 in Xenopus
embryos. Interestingly, psoriasis in humans is also
accompanied by overexpression of cyclin A (Miracco et al.,
2000), and our results suggest that this upregulation may help
drive the condition. Moreover, a number of cancers, including
those derived from skin, show elevated levels of A-type cyclins
(Balasubramanian et al., 1998; Kim et al., 2002). Our results
indicate that skin may be particularly susceptible to an increase
in cyclin A-dependent kinase level. This overexpressing
population of cells maintained in the cell cycle inappropriately
might then be targets of further genetic ‘hits’, ultimately
resulting in tumour formation. Indeed, a study looking at
UV-induced skin cancers in mice showed that cyclin A
overexpression occurs early on in the process of tumour
formation (Kim et al., 2002).
At neural plate and tailbud stages, most of the cells destined
to become neurons are still dividing and consequently express
high levels of cyclin A2/cdk2 (Hartenstein, 1989; Saka and
Smith, 2001; Vernon and Philpott, 2003a). However, a small
subset of cells found in three stripes lateral to the midline exit
the cell cycle early and differentiate into primary neurons
(Hartenstein, 1989; Lamborghini, 1980). Overexpression of
cyclin A2/cdk2 also delays differentiation of these cells (Fig.
7D-F). One can envisage several ways in which elevated cyclin
A2/cdk2 could delay primary neuron differentiation. First,
cyclin A2/cdk2 can promote cellular proliferation, preventing
cell cycle exit, which is incompatible with differentiation.
Second, we have recently shown that the cdki Xic1 is
absolutely required for differentiation of primary neurons, and
this activity extends beyond its ability to regulate the cell cycle
(Vernon et al., 2003). While the exact mechanism of Xic1
action has yet to be elucidated, cyclin A2/cdk2 overexpression
might inhibit primary neurogenesis by sequestering the
required Xic1 protein. Interestingly, however, cyclin A2/cdk2
overexpression does not delay muscle differentiation, a process
also shown to be Xic1-dependent, again showing that different
tissues may rely on distinct molecular methods to regulate the
balance between proliferation and differentiation. Third, the
levels of the myogenic factor MyoD are regulated by ubiquitin-
mediated proteolysis (e.g. Reynaud et al., 2000; Tintignac et
al., 2000), which is, in turn, controlled by cell cycle kinases
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and inhibitors. It is possible that proneural gene products are
similarly regulated. We are currently investigating this
possibility.
Our results demonstrate that overexpression of a single
cyclin/cdk pair in a vertebrate can have substantial effects on
the balance between division and differentiation in the early
embryo, in a tissue-specific manner. Studies in experimentally
tractable systems, such as those described here in Xenopus
embryos, may prove very informative for understanding
the role of cyclin/cdk upregulation in diseases of
hyperproliferation, such as psoriasis and cancer, in which it
might affect both cell proliferation and differentiation in a
tissue-dependent manner.
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